These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38247606)

  • 1. Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in
    Abdul-Mutakabbir JC; Opoku NS; Tan KK; Jorth P; Nizet V; Fletcher HM; Kaye KS; Rybak MJ
    Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli.
    Zhang Y; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Wang H
    J Antimicrob Chemother; 2020 Sep; 75(9):2609-2615. PubMed ID: 32591806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
    Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retained colistin susceptibility in clinical
    Zafer MM; Hussein AFA; Al-Agamy MH; Radwan HH; Hamed SM
    Front Cell Infect Microbiol; 2023; 13():1229473. PubMed ID: 37600939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant
    Abdul-Mutakabbir JC; Yim J; Nguyen L; Maassen PT; Stamper K; Shiekh Z; Kebriaei R; Shields RK; Castanheira M; Kaye KS; Rybak MJ
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356801
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant
    Carrasco LDM; Dabul ANG; Boralli CMDS; Righetto GM; Carvalho ISE; Dornelas JV; Martins da Mata CPS; de Araújo CA; Leite EMM; Lincopan N; Camargo ILBDC
    Front Microbiol; 2021; 12():622704. PubMed ID: 33897637
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii.
    Seleim SM; Mostafa MS; Ouda NH; Shash RY
    Sci Rep; 2022 Dec; 12(1):20951. PubMed ID: 36470921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206.
    Bruss J; Lister T; Gupta VK; Stone E; Morelli L; Lei Y; Melnick D
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0073921. PubMed ID: 34339267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates.
    Wang Y; Ma Y; Xiong L; Wang X; Zhou Y; Chi X; Chen T; Fu H; Luo Q; Xiao Y
    J Microbiol Immunol Infect; 2024 Apr; 57(2):300-308. PubMed ID: 38350840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
    Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
    Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility profile of
    Sharma S; Banerjee T; Yadav G; Kumar A
    Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
    Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
    Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
    Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
    Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
    mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant
    Rodjun V; Houngsaitong J; Montakantikul P; Paiboonvong T; Khuntayaporn P; Yanyongchaikit P; Sriyant P
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant
    Chen DJ; Cui AL; Chen JR; Yang P; Jin J; Shao L; Li ZR
    Microb Drug Resist; 2021 Jul; 27(7):933-941. PubMed ID: 33544031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.
    Arroyo LA; Herrera CM; Fernandez L; Hankins JV; Trent MS; Hancock RE
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3743-51. PubMed ID: 21646482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
    Razavi Nikoo H; Ardebili A; Mardaneh J
    Microb Drug Resist; 2017 Sep; 23(6):744-756. PubMed ID: 28085571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.